Nitiraj Engineers Limited (NSE:NITIRAJ)

Verve Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	1,975	2,728	1,778	726	747	490
Market Cap Growth	53.45%	53.45%	144.81%	-2.81%	52.51%	-13.80%
Enterprise Value	1,776	2,679	1,749	718	799	491
Last Close Price	192.71	266.15	172.37	70.41	72.44	47.50
PE Ratio	40.92	56.48	14.77	-	-	13.85
PS Ratio	2.58	3.57	1.77	1.58	1.89	0.92
PB Ratio	2.39	3.30	2.23	1.08	1.10	0.69
P/TBV Ratio	2.54	3.51	2.29	1.11	1.14	0.75
P/FCF Ratio	24.92	34.42	11.51	-	-	-
P/OCF Ratio	13.91	19.22	9.95	102.55	51.43	31.73
EV/Sales Ratio	2.32	3.50	1.74	1.56	2.02	0.92
EV/EBITDA Ratio	17.18	25.91	9.35	21.29	48.46	5.99
EV/EBIT Ratio	26.02	39.25	11.20	1868.83	-	9.61
EV/FCF Ratio	22.40	33.79	11.32	-	-	-
Debt / Equity Ratio	0	0	0.00	0.05	0.06	0.01
Debt / EBITDA Ratio	0.00	0.00	0.01	0.89	2.10	0.08
Debt / FCF Ratio	0.00	0.00	0.02	-	-	-
Asset Turnover	0.83	0.83	1.18	0.59	0.51	0.68
Inventory Turnover	2.16	2.16	2.84	1.29	1.50	2.05
Quick Ratio	3.49	3.49	3.05	0.66	1.07	1.69
Current Ratio	6.26	6.26	5.54	3.16	3.70	5.28
Return on Equity (ROE)	5.95%	5.95%	16.35%	-0.34%	-5.08%	5.04%
Return on Assets (ROA)	4.65%	4.65%	11.46%	0.03%	-0.99%	4.05%
Return on Capital (ROIC)	5.24%	5.24%	12.96%	0.03%	-1.08%	4.36%
Return on Capital Employed (ROCE)	8.00%	8.00%	19.10%	0.10%	-	7.00%
Earnings Yield	2.45%	1.77%	6.77%	-0.32%	-4.72%	7.22%
FCF Yield	4.01%	2.90%	8.69%	-0.21%	-3.65%	-2.38%
Dividend Yield	0.78%	0.56%	0.87%	-	-	-
Payout Ratio	31.83%	31.83%	-	-	-	-
Buyback Yield / Dilution	-0.06%	-0.06%	-	-	-	0.09%
Total Shareholder Return	0.72%	0.51%	0.87%	-	-	0.09%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.